ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

ACS Elects New Volunteer Leaders

November 19, 2010

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002